tiprankstipranks
Trending News
More News >

Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%

Bio-Rad (BIO) is providing its financial outlook for the full year 2025. The company currently expects non-GAAP, currency-neutral revenue growth of approximately 1.5% to 3.5% and an estimated non-GAAP operating margin of approximately 13.0% to 13.5%.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue